Clearline Capital LP - 31 Dec 2024 SCHEDULE 13G Report for TherapeuticsMD, Inc. Common Stock, par value $0.001 per share (TXMD)

Filing Manager
Clearline Capital LP
Reporting Manager
Clearline Capital LP
Security
TherapeuticsMD, Inc. Common Stock, par value $0.001 per share
Symbol
TXMD
Shares outstanding
11,549,491 shares
Disclosed Ownership
635,222 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
12 Feb 2025, 16:25:45 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Clearline Capital LP 5.5% 635,222 0 635,222 Marc Majzner Limited Partner
Clearline Capital, LLC 5.5% 635,222 0 635,222 Marc Majzner Managing Member
Marc Majzner 5.5% 635,222 0 635,222 Marc Majzner Authorized Signatory